US5019556A
(en)
*
|
1987-04-14 |
1991-05-28 |
President And Fellows Of Harvard College |
Inhibitors of angiogenin
|
CA1340323C
(en)
*
|
1988-09-20 |
1999-01-19 |
Arnold E. Hampel |
Rna catalyst for cleaving specific rna sequences
|
US5866701A
(en)
*
|
1988-09-20 |
1999-02-02 |
The Board Of Regents For Northern Illinois University Of Dekalb |
HIV targeted hairpin ribozymes
|
US5624824A
(en)
*
|
1989-03-24 |
1997-04-29 |
Yale University |
Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
|
US5168053A
(en)
*
|
1989-03-24 |
1992-12-01 |
Yale University |
Cleavage of targeted RNA by RNAase P
|
DE4091533T
(de)
*
|
1989-08-31 |
1992-01-30 |
|
|
US5225347A
(en)
*
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Therapeutic ribozyme compositions and expression vectors
|
US5225337A
(en)
*
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Ribozyme compositions and methods for use
|
DE3933384A1
(de)
*
|
1989-10-06 |
1991-04-18 |
Hoechst Ag |
Multifunktionelle rna mit selbstprozessierungsaktivitaet, ihre herstellung und ihre verwendung
|
DE3935473A1
(de)
*
|
1989-10-25 |
1991-05-02 |
Hoechst Ag |
Rna mit endonuclease- und antisense-aktivitaet, ihre herstellung und ihre verwendung
|
EP0604409B1
(de)
*
|
1990-01-11 |
2004-07-14 |
Isis Pharmaceuticals, Inc. |
Oligonukleotidderivate zur detektieren und modulation von rna aktivität und genexpression
|
US5519164A
(en)
*
|
1990-02-01 |
1996-05-21 |
Hoechst Aktiengesellschaft |
Expression of a multigene RNA having self-splicing activity
|
DE4002885A1
(de)
*
|
1990-02-01 |
1991-08-08 |
Hoechst Ag |
Expression einer multigen rna mit self-splicing aktivitaet
|
US5180818A
(en)
*
|
1990-03-21 |
1993-01-19 |
The University Of Colorado Foundation, Inc. |
Site specific cleavage of single-stranded dna
|
WO1991018913A1
(en)
*
|
1990-06-07 |
1991-12-12 |
City Of Hope |
Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna
|
WO1991018625A1
(en)
*
|
1990-06-07 |
1991-12-12 |
City Of Hope |
Ribozyme mediated reversal of transformation by cleavage of the hras oncogene rna
|
US6008343A
(en)
*
|
1990-06-19 |
1999-12-28 |
Gene Shears Pty. Ltd. |
Nucleotide based endonucleases
|
ATE150789T1
(de)
*
|
1990-06-19 |
1997-04-15 |
Gene Shears Pty Ltd |
Endonukleasen
|
CA2086105A1
(en)
*
|
1990-06-26 |
1991-12-27 |
Premkumar Reddy |
Method for treating leukemias
|
US5246921A
(en)
*
|
1990-06-26 |
1993-09-21 |
The Wistar Institute Of Anatomy And Biology |
Method for treating leukemias
|
AU8294291A
(en)
*
|
1990-07-26 |
1992-02-18 |
Foundation For Research And Technology - Hellas (Fo.R.T.H.) Institute Of Molecular Biology & Biotechnology |
Portable ribozyme cassettes, dna sequences containing them, ribozymes encoded by these dna sequences, and compositions containing these ribozymes
|
PL169576B1
(pl)
|
1990-10-12 |
1996-08-30 |
Max Planck Gesellschaft |
Sposób wytwarzania czasteczki RNA o aktywnosci katalitycznej PL PL
|
NZ241311A
(en)
*
|
1991-01-17 |
1995-03-28 |
Gen Hospital Corp |
Rna sequence having trans-splicing activity, plant strains
|
NZ314629A
(en)
*
|
1991-01-17 |
2000-08-25 |
Gen Hospital Corp |
Use trans-splicing ribozymes to prepare medicaments for gene therapies
|
FR2675803B1
(fr)
*
|
1991-04-25 |
1996-09-06 |
Genset Sa |
Oligonucleotides fermes, antisens et sens et leurs applications.
|
FI913197A0
(fi)
|
1991-07-01 |
1991-07-01 |
Xyrofin Oy |
Nya jaeststammar med reducerad foermaoga att metabolisera xylitol, foerfarande foer bildande av dessa och deras anvaendning vid framstaellning av xylitol.
|
AU683011B2
(en)
*
|
1992-01-13 |
1997-10-30 |
Duke University |
Enzymatic RNA molecules
|
US5491080A
(en)
*
|
1992-04-17 |
1996-02-13 |
Kirin Beer Kabushiki Kaisha |
Plants resistant against plural viruses and method for producing them using as RNase genes
|
RU94046396A
(ru)
*
|
1992-06-29 |
1996-11-10 |
Джин Ширс Пти.Лтд. (AU) |
Нуклеиновая кислота, днк, вектор, способ получения растения или животного, способ получения клеток, способ создания животного, животное, трансгенное животное, трансгенное растение, плоды, черенки и семена, растительные клетки, способ вмешательства в репликацию вируса
|
US5631115A
(en)
*
|
1992-07-02 |
1997-05-20 |
Sankyo Company, Limited |
Looped, hairpin ribozyme
|
US5409823A
(en)
*
|
1992-09-24 |
1995-04-25 |
Ciba-Geigy Corporation |
Methods for the production of hybrid seed
|
US5864028A
(en)
*
|
1992-11-03 |
1999-01-26 |
Gene Shears Pty. Limited |
Degradation resistant mRNA derivatives linked to TNF-α ribozymes
|
EP0672133B1
(de)
*
|
1992-11-03 |
2004-06-16 |
Gene Shears Pty Limited |
TNF-alpha RIBOZYME UND ABBAU-RESISTENTE mRNA DERIVATIVE GEBUNDEN AN TNF-alpha Ribozyme
|
CA2150903A1
(en)
*
|
1992-12-04 |
1994-06-23 |
American Home Products Corporation |
Compounds for the treatment of leukemias
|
AU679525B2
(en)
*
|
1992-12-04 |
1997-07-03 |
Innovir Laboratories, Inc. |
Regulatable nucleic acid therapeutic and methods of use thereof
|
WO1994013833A1
(en)
*
|
1992-12-04 |
1994-06-23 |
Innovir Laboratories, Inc. |
Ribozyme amplified diagnostics
|
FR2701960B1
(fr)
*
|
1993-02-26 |
2002-09-13 |
Gene Shears Pty Ltd |
Polyribozyme apte à conférer, aux plantes, une résistance aux virus et plantes résistantes produisant ce polyribozyme.
|
US5817635A
(en)
*
|
1993-08-09 |
1998-10-06 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Modified ribozymes
|
AU5334294A
(en)
*
|
1993-10-15 |
1995-05-04 |
Dkfz Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts |
Asymmetric hammerhead ribozymes and nucleotide sequences for their construction
|
US5869248A
(en)
*
|
1994-03-07 |
1999-02-09 |
Yale University |
Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
|
US5998193A
(en)
*
|
1994-06-24 |
1999-12-07 |
Gene Shears Pty., Ltd. |
Ribozymes with optimized hybridizing arms, stems, and loops, tRNA embedded ribozymes and compositions thereof
|
US6350934B1
(en)
|
1994-09-02 |
2002-02-26 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid encoding delta-9 desaturase
|
US5683873A
(en)
*
|
1995-01-13 |
1997-11-04 |
Innovir Laboratories, Inc. |
EGS-mediated inactivation of target RNA
|
US6057153A
(en)
*
|
1995-01-13 |
2000-05-02 |
Yale University |
Stabilized external guide sequences
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
AU708995B2
(en)
*
|
1995-06-07 |
1999-08-19 |
Gene Shears Pty. Limited |
Optimized minizymes and miniribozymes and uses thereof
|
US6004806A
(en)
*
|
1995-06-07 |
1999-12-21 |
Commonwealth Scientific And Industrial Research Organization |
Optimized minizymes and miniribozymes and uses thereof
|
US6010904A
(en)
*
|
1995-06-07 |
2000-01-04 |
The General Hospital Corporation |
Cell ablation using trans-splicing ribozymes
|
JPH11509733A
(ja)
*
|
1995-07-13 |
1999-08-31 |
リボザイム・ファーマシューティカルズ・インコーポレーテッド |
植物における遺伝子発現調節のための組成物および方法
|
US5824519A
(en)
*
|
1995-11-08 |
1998-10-20 |
Medical University Of South Carolina |
Tissue-specific and target RNA-specific ribozymes
|
US5877162A
(en)
*
|
1996-03-14 |
1999-03-02 |
Innovir Laboratories, Inc. |
Short external guide sequences
|
US6620805B1
(en)
|
1996-03-14 |
2003-09-16 |
Yale University |
Delivery of nucleic acids by porphyrins
|
US6610478B1
(en)
|
1996-08-16 |
2003-08-26 |
Yale University |
Phenotypic conversion of cells mediated by external guide sequences
|
US5976874A
(en)
*
|
1996-08-16 |
1999-11-02 |
Yale University |
Phenotypic conversion of drug-resistant bacteria to drug-sensitivity
|
US6884430B1
(en)
|
1997-02-10 |
2005-04-26 |
Aventis Pharma S.A. |
Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
|
US6969601B2
(en)
|
1997-04-03 |
2005-11-29 |
Jensenius Jens Chr |
MASP-2, a complement-fixing enzyme, and uses for it
|
US7589253B2
(en)
|
1997-04-15 |
2009-09-15 |
Commonwealth Scientific And Industrial Research Organisation |
Fatty acid epoxygenase genes from plants and uses therefor in modifying fatty acid metabolism
|
KR100711074B1
(ko)
|
1997-04-15 |
2007-04-26 |
커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 |
식물의 지방산 에폭시게나제 유전자 및 이의 용도
|
IL133710A0
(en)
|
1997-06-30 |
2001-04-30 |
Rhone Poulence Rorer S A |
Improved method for transferring nucleic acid into the striped muscle and combination thereof
|
JP2001516582A
(ja)
|
1997-09-16 |
2001-10-02 |
クロップデザイン エヌ.ブイ. |
サイクリン依存性キナーゼ阻害物質およびその使用
|
DE19741375C2
(de)
*
|
1997-09-19 |
1999-10-21 |
Max Planck Gesellschaft |
Transgene Pflanzen, deren oberirdische Teile früher reifen und vollständig absterben
|
ES2221212T5
(es)
|
1997-10-02 |
2008-12-01 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Metodos para la modulacion de la neovascularizacion y/o el crecimiento de arterias colaterales y/o de otras arterias a partir de conexiones arteriolares preexistentes.
|
JP4749541B2
(ja)
|
1997-11-18 |
2011-08-17 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
レスポンダー表現型に関わる核酸およびその適用
|
US6013447A
(en)
*
|
1997-11-21 |
2000-01-11 |
Innovir Laboratories, Inc. |
Random intracellular method for obtaining optimally active nucleic acid molecules
|
CZ295108B6
(cs)
|
1998-03-20 |
2005-05-18 |
Benitec Australia Ltd |
Syntetický gen obsahující dispergovanou nebo cizorodou deoxyribonukleovou molekulu a genový konstrukt obsahující tento syntetický gen
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
US6248525B1
(en)
|
1998-03-30 |
2001-06-19 |
Yale University |
Method for identifying essential or functional genes
|
AU4830899A
(en)
|
1998-06-24 |
2000-01-10 |
Musc Foundation For Research Development |
Tissue-specific and target rna-specific ribozymes
|
DE19836098A1
(de)
|
1998-07-31 |
2000-02-03 |
Hoechst Schering Agrevo Gmbh |
Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke
|
EP1121437B1
(de)
|
1998-10-15 |
2008-02-20 |
Novartis Vaccines and Diagnostics, Inc. |
Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
|
CA2348366C
(en)
*
|
1998-11-09 |
2012-05-15 |
Planttec Biotechnologie Gmbh |
Nucleic acid molecules from rice and their use for the production of modified starch
|
TR200101342T2
(tr)
|
1998-11-12 |
2001-09-21 |
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften |
Patojen enfeksiyonu üzerine bitkilerde gen ekspresyonuna aracılık edebilen şimerik promoterler
|
AU2367600A
(en)
|
1998-12-16 |
2000-07-03 |
Chiron Corporation |
Human cyclin-dependent kinase ((hpnqalre))
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
AUPQ005299A0
(en)
|
1999-04-29 |
1999-05-27 |
Commonwealth Scientific And Industrial Research Organisation |
Novel genes encoding wheat starch synthases and uses therefor
|
ES2250173T3
(es)
|
1999-07-20 |
2006-04-16 |
Gvs Gesellschaft Fur Erwerb Und Verwertung Von Schutzrechten Mbh |
Nuevo metodo para la generacion y seleccion de plantas de linaza o lino transgenicas.
|
US6423885B1
(en)
|
1999-08-13 |
2002-07-23 |
Commonwealth Scientific And Industrial Research Organization (Csiro) |
Methods for obtaining modified phenotypes in plant cells
|
WO2002007773A2
(en)
|
2000-07-21 |
2002-01-31 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
DK1331845T3
(da)
|
2000-11-09 |
2012-04-23 |
Commw Scient Ind Res Org |
Byg med reduceret SSII-aktivitet og stivelsesholdige produkter med et reduceret indhold af amylopectin
|
ITMI20011364A1
(it)
*
|
2001-06-28 |
2002-12-28 |
Metapontum Agrobios S C R L |
Robozima hammerhead specifico per la stearoyl-acp desaturesi di piante oleaginose differenti
|
ES2358187T3
(es)
|
2001-07-10 |
2011-05-06 |
JOHNSON & JOHNSON RESEARCH PTY LIMITED |
Procedimientos para la modificación genética de las células progenitoras hematopoyéticas y utilizaciones de las células modificadas.
|
IL159637A0
(en)
|
2001-07-10 |
2004-06-01 |
Johnson & Johnson Res Pty Ltd |
Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
|
US8022272B2
(en)
|
2001-07-13 |
2011-09-20 |
Sungene Gmbh & Co. Kgaa |
Expression cassettes for transgenic expression of nucleic acids
|
FR2829136B1
(fr)
|
2001-08-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives lipidiques d'aminoglycosides
|
US7456335B2
(en)
|
2001-09-03 |
2008-11-25 |
Basf Plant Science Gmbh |
Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
|
EP1427856B1
(de)
|
2001-09-18 |
2011-05-11 |
Carnegie Institution Of Washington |
Fusionsproteine zur detektion von analyten
|
WO2003051314A2
(en)
|
2001-12-18 |
2003-06-26 |
Medallion Biomedical, Llc |
Antibiotic compounds
|
US20040005546A1
(en)
|
2002-02-28 |
2004-01-08 |
Oncolytics Biotech Inc. |
Use of ribozymes in the detection of adventitious agents
|
DE10212892A1
(de)
|
2002-03-20 |
2003-10-09 |
Basf Plant Science Gmbh |
Konstrukte und Verfahren zur Regulation der Genexpression
|
EP1365034A3
(de)
|
2002-05-21 |
2004-02-18 |
Bayer HealthCare AG |
Verfahren und Zusammensetzungen zur Vorhersage, Diagnose, Prognose, Prävention und Behandlung von malignen Tumoren
|
CA2542171C
(en)
|
2002-06-26 |
2015-12-15 |
Abbott Gmbh & Co. Kg |
Modulators and modulation of the interaction between rgm and neogenin
|
DE50310378D1
(de)
|
2002-07-26 |
2008-10-02 |
Basf Plant Science Gmbh |
Neue selektionsverfahren
|
EP2258724A1
(de)
|
2002-11-21 |
2010-12-08 |
Celltech R & D, Inc. |
Modulierung von Immunantworten mittels multimeriserter Anti-CD83 Antikörper
|
AU2003293991B2
(en)
|
2002-12-19 |
2009-01-22 |
Bayer Intellectual Property Gmbh |
Plant cells and plants which synthesize a starch with an increased final viscosity
|
PL1625166T3
(pl)
|
2003-05-12 |
2015-08-31 |
Helion Biotech Aps |
Przeciwciała przeciwko masp-2
|
ATE517994T1
(de)
|
2003-06-30 |
2011-08-15 |
Commw Scient Ind Res Org |
Weizen mit veränderter verzweigungsenzymaktivität sowie daraus erhaltene stärke und stärkehaltige produkte
|
EP1892306A3
(de)
|
2003-10-06 |
2008-06-11 |
Bayer HealthCare AG |
Verfahren und Kit zur Untersuchung von Krebs
|
EP1602926A1
(de)
|
2004-06-04 |
2005-12-07 |
University of Geneva |
Neue Mittel und Verfahren zur Behandlung von Gehörverlust oder Tinnitus
|
US7604947B2
(en)
|
2004-06-09 |
2009-10-20 |
Cornell Research Foundation, Inc. |
Detection and modulation of cancer stem cells
|
US8840893B2
(en)
|
2004-06-10 |
2014-09-23 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
CA2847677C
(en)
|
2004-06-10 |
2018-05-01 |
Omeros Corporation |
Methods for treating conditions associated with masp-2 dependent complement activation
|
US7919094B2
(en)
|
2004-06-10 |
2011-04-05 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
EP1763582B1
(de)
|
2004-07-08 |
2014-12-10 |
DLF - Trifolium A/S |
Mittel und Verfahren zur Steuerung der Blüte in Pflanzen
|
EP2163635B1
(de)
|
2004-08-02 |
2013-05-22 |
BASF Plant Science GmbH |
Verfahren zur Isolierung von Transkriptionsabschlusssequenzen
|
CA2579927A1
(en)
|
2004-09-24 |
2006-03-30 |
Basf Plant Science Gmbh |
Plant cells and plants with increased tolerance to environmental stress
|
CA2594155C
(en)
|
2004-12-30 |
2016-08-30 |
Commonwealth Scientific And Industrial Research Organisation |
A process for producing a food or beverage
|
EP1707632A1
(de)
|
2005-04-01 |
2006-10-04 |
Bayer CropScience GmbH |
Phosphorylierte waxy-Kartoffelstärke
|
CN101277974A
(zh)
|
2005-09-30 |
2008-10-01 |
阿伯特有限及两合公司 |
排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途
|
WO2007054441A2
(de)
|
2005-11-08 |
2007-05-18 |
Basf Plant Science Gmbh |
Verwendung von armadillo-repeat (arm1)-polynukleotiden zum erreichen einer pathogenresistenz in pflanzen
|
EP1979484B1
(de)
|
2006-01-12 |
2014-03-19 |
BASF Plant Science GmbH |
Verwendung von stomatin (stm1)-polynukleotiden zur erreichung einer resistenz gegen krankheitserreger von pflanzen
|
WO2008034648A1
(en)
|
2006-04-05 |
2008-03-27 |
Metanomics Gmbh |
Process for the production of a fine chemical
|
WO2007134818A2
(en)
|
2006-05-18 |
2007-11-29 |
Univ Muenchen L Maximilians |
Method for diagnosing mitochondrial dysfunction
|
US8383597B2
(en)
|
2006-05-25 |
2013-02-26 |
Cornell Research Foundation, Inc. |
G proteins in tumor growth and angiogenesis
|
ES2520023T3
(es)
|
2006-10-06 |
2014-11-11 |
Speedx Pty Ltd |
Interruptores moleculares y métodos para su uso
|
DK2202314T3
(da)
|
2007-01-15 |
2014-06-16 |
Basf Plant Science Gmbh |
Anvendelse af subtilisin (RNR9)-polynukleotider til opnåelse af patogenresistens i planter
|
AU2008214568B2
(en)
|
2007-02-16 |
2013-04-18 |
Basf Plant Science Gmbh |
Nucleic acid sequences for regulation of embryo-specific expression in monocotyledonous plants
|
NZ580413A
(en)
|
2007-03-27 |
2012-11-30 |
Omeros Corp |
The use of pde7 inhibitors for the treatment of movement disorders
|
DE112008001453T5
(de)
|
2007-05-22 |
2010-04-29 |
Basf Plant Science Gmbh |
Pflanzenzellen und Pflanzen mit erhöhter Toleranz und/oder Resistenz gegenüber Umweltstress und erhöhter Biomasseproduktion-KO
|
CL2008002775A1
(es)
|
2007-09-17 |
2008-11-07 |
Amgen Inc |
Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
|
EP2040075A1
(de)
|
2007-09-24 |
2009-03-25 |
Julius-Maximilians-Universität Würzburg |
Verbindungen und Marker für oberflächenverstärkte Raman-Streuung
|
US20110044978A1
(en)
|
2007-12-14 |
2011-02-24 |
Amgen Inc. |
Method for treating bone fracture
|
BRPI0821009A2
(pt)
|
2007-12-21 |
2019-09-24 |
Basf Plant Science Gmbh |
métodos para aumentar o rendimento de uma planta e para produzir uma célula de planta transgênica, uma planta ou uma parte e para determinar o teor de nitrogênio de solo de teste, moléculas, moléculas de ácido nucléico isolada e de ácido nucleico viral, oligoiniciador, mutante negativo dominante de polipeptideo, construto de ácido nucleico, vetor, célula de planta transgênica, planta ou uma parte da mesma, polipeptideo, anticorpo, tecido de planta, planta, material de planta colhida ou material de propagação de uma planta, processo para produzir um polipeptideo, composição de alimento ou ração, e, uso
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
EP2100962A1
(de)
|
2008-03-12 |
2009-09-16 |
Biogemma |
Pflanzen mit verbesserter Widerstandsfähigkeit gegen Pathogene
|
US10517839B2
(en)
|
2008-06-09 |
2019-12-31 |
Cornell University |
Mast cell inhibition in diseases of the retina and vitreous
|
US8790664B2
(en)
|
2008-09-05 |
2014-07-29 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Multimodular assembly useful for intracellular delivery
|
EP2184351A1
(de)
|
2008-10-30 |
2010-05-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Polynukleotid-kondierende Caryophyllen-Synthase und ihre Verwendung
|
ES2363358B1
(es)
|
2009-04-03 |
2012-06-21 |
FUNDACIÓ INSTITUT DE RECERCA HOSPITAL UNIVERSITARI VALL D'HEBRON (Titular al |
Agentes terapéuticos para el tratamiento de enfermedades asociadas con una proliferación celular indeseable.
|
CA3020943A1
(en)
|
2009-04-22 |
2010-10-28 |
Basf Plant Science Company Gmbh |
Whole seed specific promoter
|
US20130012709A1
(en)
|
2009-09-10 |
2013-01-10 |
Centre National De La Recherche Scientifique |
NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
|
EP2305285A1
(de)
|
2009-09-29 |
2011-04-06 |
Julius-Maximilians-Universität Würzburg |
Mittel und Verfahren zur Behandlung von ischämischen Erkrankungen
|
NZ599906A
(en)
|
2009-10-16 |
2014-05-30 |
Univ Leicester |
Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation
|
JP5806672B2
(ja)
|
2009-10-30 |
2015-11-10 |
ドメイン・セラピューティクス |
新規オキシム誘導体及び代謝型グルタミン酸受容体のアロステリック調節因子としての利用
|
EP2322149A1
(de)
|
2009-11-03 |
2011-05-18 |
Universidad del Pais Vasco |
Verfahren und Zusammensetzung zur Behandlung von Ischämie
|
ES2562832T3
(es)
|
2009-12-08 |
2016-03-08 |
Abbvie Deutschland Gmbh & Co Kg |
Anticuerpos monoclonales contra la proteína RGM para su uso en el tratamiento de la degeneración de la capa de fibra nerviosa de la retina
|
EP2338492A1
(de)
|
2009-12-24 |
2011-06-29 |
Universidad del Pais Vasco |
Verfahren und Zusammensetzung zur Behandlung von Alzheimer
|
US8476485B2
(en)
|
2010-06-24 |
2013-07-02 |
Academia Sinica |
Non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 function
|
US9220715B2
(en)
|
2010-11-08 |
2015-12-29 |
Omeros Corporation |
Treatment of addiction and impulse-control disorders using PDE7 inhibitors
|
NZ628055A
(en)
|
2010-11-08 |
2016-03-31 |
Omeros Corp |
Treatment of addiction and impulse-control disorders using pde7 inhibitors
|
US9644035B2
(en)
|
2011-04-08 |
2017-05-09 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
ES2683307T3
(es)
|
2011-04-08 |
2018-09-26 |
University Of Leicester |
Métodos para tratar afecciones asociadas con la activación de complemento dependiente de MASP-2
|
AU2012333134B2
(en)
|
2011-07-22 |
2017-05-25 |
John Paul Guilinger |
Evaluation and improvement of nuclease cleavage specificity
|
WO2013025936A1
(en)
|
2011-08-18 |
2013-02-21 |
Cornell University |
Detection and treatment of metastatic disease
|
WO2013039880A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Biomarkers and therapeutic targets of hepatocellular cancer
|
WO2013090814A2
(en)
|
2011-12-16 |
2013-06-20 |
Board Of Trustees Of Michigan State University |
p-Coumaroyl-CoA:Monolignol Transferase
|
DK2807192T3
(en)
|
2012-01-27 |
2018-07-23 |
Abbvie Deutschland |
COMPOSITION AND PROCEDURE FOR DIAGNOSTICATION AND TREATMENT OF DISEASES RELATED TO NEURITE DEGENERATION
|
WO2013138463A1
(en)
|
2012-03-14 |
2013-09-19 |
University Of Central Florida Research Foundation, Inc. |
Neurofibromatoses therapeutic agents and screening for same
|
EP2666775A1
(de)
|
2012-05-21 |
2013-11-27 |
Domain Therapeutics |
Substituierte Pyrazolochinazolinone und Pyrrolochinazolinone als allosterische Modulatoren von metabotropen Glutamatrezeptoren der Gruppe II
|
WO2014127835A1
(en)
|
2013-02-22 |
2014-08-28 |
Christian-Albrechts-Universität Zu Kiel |
Plant-derived resistance gene
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
PT3057993T
(pt)
|
2013-10-17 |
2020-11-19 |
Omeros Corp |
Métodos de tratamento das condições associadas à ativação do complemento dependente do masp-2
|
CN111154724B
(zh)
|
2013-12-18 |
2024-02-06 |
联邦科学技术研究组织 |
包含二十二碳六烯酸的提取的植物脂质
|
EP3160482A4
(de)
|
2014-06-27 |
2018-02-14 |
Commonwealth Scientific and Industrial Research Organisation |
Lipid mit docosapentensäure
|
EP3000814A1
(de)
|
2014-09-26 |
2016-03-30 |
Domain Therapeutics |
Substituierte Pyrazolochinazolinone und Pyrrolochinazolinone als allosterische Modulatoren von metabotropen Glutamatrezeptoren der Gruppe II
|
AU2016342380B2
(en)
|
2015-10-23 |
2022-04-07 |
President And Fellows Of Harvard College |
Nucleobase editors and uses thereof
|
BR112018009311A8
(pt)
|
2015-11-09 |
2019-02-26 |
Omeros Corporation E Univ Of Leicester |
?método para tratar um sujeito humano sofrendo de tma persistente associada com transplante de célula tronco hematopoiética?
|
UA127339C2
(uk)
|
2016-01-05 |
2023-07-26 |
Юніверсіті Оф Лестер |
СПОСІБ ПРОФІЛАКТИКИ АБО ЗМЕНШЕННЯ УРАЖЕННЯ НИРОК У СУБ'ЄКТА, ЩО СТРАЖДАЄ НА СТЕРОЇДЗАЛЕЖНУ ІМУНОГЛОБУЛІН-А-НЕФРОПАТІЮ (IgAN)
|
SG10202009886SA
(en)
|
2016-03-31 |
2020-11-27 |
Omeros Corp |
Methods for inhibiting angiogenesis in a subject in need thereof
|
IL262975B2
(en)
|
2016-05-26 |
2023-03-01 |
Nunhems Bv |
Plants that produce fruit without pits
|
AU2017306676B2
(en)
|
2016-08-03 |
2024-02-22 |
President And Fellows Of Harvard College |
Adenosine nucleobase editors and uses thereof
|
CN109804066A
(zh)
|
2016-08-09 |
2019-05-24 |
哈佛大学的校长及成员们 |
可编程cas9-重组酶融合蛋白及其用途
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
US11873496B2
(en)
|
2017-01-09 |
2024-01-16 |
Whitehead Institute For Biomedical Research |
Methods of altering gene expression by perturbing transcription factor multimers that structure regulatory loops
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
US10883089B2
(en)
|
2017-04-04 |
2021-01-05 |
Wisconsin Alumni Research Foundation |
Feruloyl-CoA:monolignol transferases
|
US10883090B2
(en)
|
2017-04-18 |
2021-01-05 |
Wisconsin Alumni Research Foundation |
P-coumaroyl-CoA:monolignol transferases
|
WO2019018451A2
(en)
|
2017-07-17 |
2019-01-24 |
The Regents Of The University Of Colorado |
COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED PROXIMITY EFFECTS CAUSED BY RADIATION OR RADIATION THERAPY
|
JP2020534795A
(ja)
|
2017-07-28 |
2020-12-03 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ファージによって支援される連続的進化(pace)を用いて塩基編集因子を進化させるための方法および組成物
|
TW202402809A
(zh)
|
2017-08-15 |
2024-01-16 |
美商歐米諾斯公司 |
用於治療和/或預防與造血幹細胞移植有關的移植物抗宿主病和/或瀰漫性肺泡出血和/或靜脈閉塞性病的方法
|
EP3676376A2
(de)
|
2017-08-30 |
2020-07-08 |
President and Fellows of Harvard College |
Hocheffiziente baseneditoren mit gam
|
CA3082251A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
US11584714B2
(en)
|
2018-05-29 |
2023-02-21 |
Omeros Corporation |
MASP-2 inhibitors and methods of use
|
US11291176B2
(en)
|
2018-06-15 |
2022-04-05 |
Nunhems B.V. |
Seedless watermelon plants comprising modifications in an ABC transporter gene
|
CA3119066A1
(en)
|
2018-11-09 |
2020-05-14 |
Wisconsin Alumni Research Foundation |
Bahd acyltransferases
|
CN114729365A
(zh)
|
2019-03-19 |
2022-07-08 |
布罗德研究所股份有限公司 |
用于编辑核苷酸序列的方法和组合物
|
BR112022010895A2
(pt)
|
2019-12-04 |
2022-09-06 |
Omeros Corp |
Composto, composição farmacêutica, e, método para tratar uma doença ou distúrbio associado à serina protease-2 associada à lectina de ligação ao manan
|
WO2021113698A1
(en)
|
2019-12-04 |
2021-06-10 |
Omeros Corporation |
Masp-2 inhibitors and methods of use
|
KR20220110531A
(ko)
|
2019-12-04 |
2022-08-08 |
오메로스 코포레이션 |
Masp-2 억제자 및 사용 방법
|
EP4146804A1
(de)
|
2020-05-08 |
2023-03-15 |
The Broad Institute Inc. |
Verfahren und zusammensetzungen zur gleichzeitigen bearbeitung beider stränge einer doppelsträngigen zielnukleotidsequenz
|
EP4192952A1
(de)
|
2020-08-10 |
2023-06-14 |
Novartis AG |
Behandlungen für degenerative netzhauterkrankungen
|
WO2024038090A1
(en)
|
2022-08-18 |
2024-02-22 |
Mitodicure Gmbh |
Use of substituted benzoxazole and benzofuran compounds for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance
|
WO2024042160A1
(en)
|
2022-08-26 |
2024-02-29 |
Mitodicure Gmbh |
Use of a therapeutic agent with sodium-hydrogen antiporter 1 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance
|